Calamos Advisors
SYNH

Calamos Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Calamos Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,500
Closed -$335K – 785
2020
Q1 		$335K Buy
+8,500
New +$497K ﹤0.01% 662

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Calamos Advisors's SYNH Position: Q2 2020 in Review

Calamos Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2020, closing a stake of 8,500 shares — an estimated $335K sold.

Calamos Advisors first reported a position in SYNH in Q1 2020 and held it in 1 quarter. The position peaked at $335K in Q1 2020. 285 funds tracked by Wall St. Rank hold SYNH as of Q2 2020.

  • Calamos Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2020 after selling out during the quarter.
  • Calamos Advisors sold 8,500 Syneos Health, Inc. Class A Common Stock shares in Q2 2020, an estimated $335K.
  • Calamos Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 1 quarter.
  • Calamos Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $335K in Q1 2020.
  • 285 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2020.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.